Update to AIM Specialty Health clinical appropriateness guidelines: advanced imaging appropriate use criteria: imaging of the heart

Effective for dates of service on and after January 28, 2019, the following updates will apply to the AIM Specialty Health© (AIM), a separate company, clinical appropriateness guidelines: advanced imaging appropriate use criteria: imaging of the heart.

 

Carotid duplex ultrasound

• Criteria removed for evaluation of syncope in patients with suspected extracranial arterial disease
• New criteria address evaluation of TAVR (TAVI) in patients with suspected or established extracranial arterial disease

 

Myocardial perfusion imaging (MPI), stress echocardiography, cardiac PET, and coronary CT angiography (CCTA)

• Clarifications address exercise-induced syncope and exercise-induced dizziness, lightheadedness or near syncope in symptomatic patients with suspected coronary artery disease

 

MPI, stress echocardiography, cardiac PET

• Criteria added to allow annual surveillance of coronary artery disease in patients with established CAD post-cardiac transplant
• Clarified definition of established coronary artery disease when diagnosed by CCTA
  • more restrictive for patients diagnosed with coronary artery disease by prior coronary angiography, as FFR must be ≤0.8
  • more permissive for patients diagnosed with coronary artery disease by CCTA with FFR ≤0.8 (patients previously excluded)

 

Resting transthoracic echocardiography (TTE)

• New criteria for evaluation of ventricular function in patients who have undergone cardiac transplantation.

 

Cardiac MRI

• New criteria allows for annual study to quantify cardiac iron load in chronically ill patients with cardiomyopathy who require frequent blood transfusions (e.g., thalassemia)
• Removed allowance for annual LV function evaluation when echocardiography is suboptimal

 

As a reminder, ordering and servicing providers may submit prior authorization requests to AIM in one of several ways:

• Access AIM’s ProviderPortallSM directly at providerportal.com. Online access is available 24/7 to process orders in real-time, and is the fastest and most convenient way to request authorization.
• Access AIM via the Availity Web Portal at availity.com.
• Call the AIM Contact Center toll-free number: 1-877-430-2288, Monday–Friday, 8:00 a.m.–6:00 p.m. ET.

 

For questions related to guidelines, please contact AIM via email at aim.guidelines@aimspecialtyhealth.com. Additionally, you may access and download a copy of the current guidelines on AIM’s website.

 

Please note, this program does not apply to FEP.